G
GTBP
Gt Biopharma Inc
0.4180
-0.0072-1.69%Pre Market: 0.4200 +0.0020 +0.48%07:38 06/10 EDT
OPEN/PREV CLOSE0.4350/0.4252
TODAY RANGE0.4030-0.4350
VOL2.52K
MARKET CAP15.07M
52 WEEK RANGE0.2610-3.850
AVG VOL (3M)1.25M
% TURNOVER2.90%
TURNOVER0
P/E (TTM)-0.0342
% RANGE7.53%
EPS(TTM)-12.2132
P/E(FORWARD)-1.2294
P/B1.940
BVPS0.2155
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP14.56M
SHARES OUTSTANDING36.06M
NEXT EARNINGS08/12-08/17
FREE FLOAT34.83M
LOT SIZE1
EX-DATE02/05/2024
News
Press Releases
Financial Reports
Profile
Benzinga·06/01 12:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Reuters·06/01 12:00
GT BIOPHARMA - TO EXPAND PIPELINE TARGETS BEYOND ONCOLOGY IN 2027
Benzinga·06/01 11:31
EXCLUSIVE: GT Biopharma Sees Faster Discovery, Productivity Following AI Technology Rollout
Benzinga·05/22 12:11
Nasdaq Grants GT Biopharma Additional 180 Days To Regain Compliance
Seeking Alpha·05/15 12:38
GT Biopharma reports Q1 results
Benzinga·05/15 12:19
GT Biopharma Q1 EPS $(0.11) Misses $(0.08) Estimate
PUBT·05/15 12:04
GT Biopharma Q2 FY26 net loss widens to $2.8 million
Dow Jones·05/15 12:01
*GT Biopharma: Cash Runway Through 4Q 2026 >GTBP
Dow Jones·05/15 12:01
*GT Biopharma 1Q Loss $2.8M >GTBP
Reuters·05/15 12:00
GT BIOPHARMA REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Benzinga·05/14 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Same Industry
Name/Symbol
Change%
Price